162 related articles for article (PubMed ID: 11803449)
1. Subjects with major depression or bipolar disorder show reduction of prodynorphin mRNA expression in discrete nuclei of the amygdaloid complex.
Hurd YL
Mol Psychiatry; 2002; 7(1):75-81. PubMed ID: 11803449
[TBL] [Abstract][Full Text] [Related]
2. Prodynorphin and kappa opioid receptor mRNA expression in the cingulate and prefrontal cortices of subjects diagnosed with schizophrenia or affective disorders.
Peckys D; Hurd YL
Brain Res Bull; 2001 Jul; 55(5):619-24. PubMed ID: 11576758
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of amygdala preprotachykinin A mRNA but not 3H-SP receptor binding sites in subjects affected by mood disorders and schizophrenia.
Carletti R; Corsi M; Melotto S; Caberlotto L
Eur J Neurosci; 2005 Mar; 21(6):1712-8. PubMed ID: 15845098
[TBL] [Abstract][Full Text] [Related]
4. Impaired periamygdaloid-cortex prodynorphin is characteristic of opiate addiction and depression.
Anderson SA; Michaelides M; Zarnegar P; Ren Y; Fagergren P; Thanos PK; Wang GJ; Bannon M; Neumaier JF; Keller E; Volkow ND; Hurd YL
J Clin Invest; 2013 Dec; 123(12):5334-41. PubMed ID: 24231353
[TBL] [Abstract][Full Text] [Related]
5. Spinal prodynorphin gene expression in collagen-induced arthritis: influence of the glucocorticosteroid budesonide.
Persson S; Schäfer MK; Nohr D; Ekström G; Post C; Nyberg F; Weihe E
Neuroscience; 1994 Nov; 63(1):313-26. PubMed ID: 7898656
[TBL] [Abstract][Full Text] [Related]
6. Expression of POU-domain transcription factor, Oct-6, in schizophrenia, bipolar disorder and major depression.
Ubhi K; Price J
BMC Psychiatry; 2005 Oct; 5():38. PubMed ID: 16246257
[TBL] [Abstract][Full Text] [Related]
7. Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression.
Fatemi SH; Earle JA; McMenomy T
Mol Psychiatry; 2000 Nov; 5(6):654-63, 571. PubMed ID: 11126396
[TBL] [Abstract][Full Text] [Related]
8. Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia.
López-Figueroa AL; Norton CS; López-Figueroa MO; Armellini-Dodel D; Burke S; Akil H; López JF; Watson SJ
Biol Psychiatry; 2004 Feb; 55(3):225-33. PubMed ID: 14744462
[TBL] [Abstract][Full Text] [Related]
9. Alteration in estrogen receptor alpha mRNA levels in frontal cortex and hippocampus of patients with major mental illness.
Perlman WR; Tomaskovic-Crook E; Montague DM; Webster MJ; Rubinow DR; Kleinman JE; Weickert CS
Biol Psychiatry; 2005 Nov; 58(10):812-24. PubMed ID: 16112656
[TBL] [Abstract][Full Text] [Related]
10. Ontogeny of prodynorphin gene expression in the rat hypothalamus.
Laurent-Huck FM; Anguelova E; Rene F; Stoeckel ME; Felix JM
Brain Res Dev Brain Res; 1993 Sep; 75(1):45-53. PubMed ID: 8222211
[TBL] [Abstract][Full Text] [Related]
11. Prodynorphin mRNA expression is increased in the patch vs matrix compartment of the caudate nucleus in suicide subjects.
Hurd YL; Herman MM; Hyde TM; Bigelow LB; Weinberger DR; Kleinman JE
Mol Psychiatry; 1997; 2(6):495-500. PubMed ID: 9399695
[TBL] [Abstract][Full Text] [Related]
12. Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder.
Gaughran F; Payne J; Sedgwick PM; Cotter D; Berry M
Brain Res Bull; 2006 Jul; 70(3):221-7. PubMed ID: 16861106
[TBL] [Abstract][Full Text] [Related]
13. CHRNA7 and CHRFAM7A mRNAs: co-localized and their expression levels altered in the postmortem dorsolateral prefrontal cortex in major psychiatric disorders.
Kunii Y; Zhang W; Xu Q; Hyde TM; McFadden W; Shin JH; Deep-Soboslay A; Ye T; Li C; Kleinman JE; Wang KH; Lipska BK
Am J Psychiatry; 2015 Nov; 172(11):1122-30. PubMed ID: 26206074
[TBL] [Abstract][Full Text] [Related]
14. Differences in the cellular distribution of D1 receptor mRNA in the hippocampus of bipolars and schizophrenics.
Pantazopoulos H; Stone D; Walsh J; Benes FM
Synapse; 2004 Dec; 54(3):147-55. PubMed ID: 15452863
[TBL] [Abstract][Full Text] [Related]
15. Alterations in prodynorphin gene expression and dynorphin levels in different brain regions after chronic administration of 14-methoxymetopon and oxycodone-6-oxime.
Király KP; Riba P; D'Addario C; Di Benedetto M; Landuzzi D; Candeletti S; Romualdi P; Furst S
Brain Res Bull; 2006 Jul; 70(3):233-9. PubMed ID: 16861108
[TBL] [Abstract][Full Text] [Related]
16. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders.
Webster MJ; Knable MB; O'Grady J; Orthmann J; Weickert CS
Mol Psychiatry; 2002; 7(9):985-94, 924. PubMed ID: 12399952
[TBL] [Abstract][Full Text] [Related]
17. Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder.
McCullumsmith RE; Meador-Woodruff JH
Neuropsychopharmacology; 2002 Mar; 26(3):368-75. PubMed ID: 11850151
[TBL] [Abstract][Full Text] [Related]
18. Electrical stimulation in vivo increases the expression of proenkephalin mRNA and decreases the expression of prodynorphin mRNA in rat hippocampal granule cells.
Morris BJ; Feasey KJ; ten Bruggencate G; Herz A; Höllt V
Proc Natl Acad Sci U S A; 1988 May; 85(9):3226-30. PubMed ID: 3362871
[TBL] [Abstract][Full Text] [Related]
19. Prodynorphin mRNA is synthesized in adult cultured rat ventricular cardiomyocytes.
Ventura C; Canossa M; Vaona I; Carboni L; Caldarera CM; Spampinato S; Guarnieri C
Cardioscience; 1993 Mar; 4(1):21-4. PubMed ID: 8471738
[TBL] [Abstract][Full Text] [Related]
20. mRNA and protein expression for novel GABAA receptors θ and ρ2 are altered in schizophrenia and mood disorders; relevance to FMRP-mGluR5 signaling pathway.
Fatemi SH; Folsom TD; Rooney RJ; Thuras PD
Transl Psychiatry; 2013 Jun; 3(6):e271. PubMed ID: 23778581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
